Gilead Sciences, Inc. (NASDAQ:GILD) Stock Position Raised by Stonegate Investment Group LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Farmers & Merchants Investments Inc. trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,492 shares of the biopharmaceutical company’s stock after selling 237 shares during the period. Farmers & Merchants Investments Inc.’s […]
Pinnacle Associates Ltd. lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 59,814 shares of the biopharmaceutical company’s stock after buying an additional 1,033 shares during the period. Pinnacle Associates Ltd.’s […]
Premier Path Wealth Partners LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,922 shares of the biopharmaceutical company’s stock, valued at approximately $399,000. Several other institutional investors […]
Mutual Advisors LLC lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,906 shares of the biopharmaceutical company’s stock after buying an additional 702 shares during the quarter. Mutual Advisors LLC’s holdings […]
Deutsche Bank AG decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 14.4% in the third quarter, HoldingsChannel reports. The firm owned 6,965,592 shares of the biopharmaceutical company’s stock after selling 1,167,311 shares during the quarter. Deutsche Bank AG’s holdings in Gilead Sciences were worth $522,001,000 as of its most […]
Allen Mooney & Barnes Investment Advisors LLC purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,826 shares of the biopharmaceutical company’s stock, valued at approximately $1,561,000. Other large investors have […]
SkyView Investment Advisors LLC cut its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 51.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,299 shares of the biopharmaceutical company’s stock after selling 6,660 shares during the quarter. SkyView Investment Advisors LLC’s […]
Deutsche Bank AG trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 14.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,965,592 shares of the biopharmaceutical company’s stock after selling 1,167,311 shares during the period. Deutsche […]
Deutsche Bank AG trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 14.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,965,592 shares of the biopharmaceutical company’s stock after selling 1,167,311 shares during the period. Deutsche […]